HHealth Read More Disrupted brain-immune signaling may help drive neurodegenerationAugust 24, 2026 From gut-primed T cells to microglial signaling and persistent gene-regulatory states, researchers map an intricate immune network that…
HHealth Read More First-in-class experimental CAR T-cell therapy shows promise against solid tumorsJuly 3, 2026 Researchers with the Charbonneau Cancer Institute at the University of Calgary and McMaster University have identified a unique…
HHealth Read More Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concernsApril 24, 2026 A newly characterized bat coronavirus can latch onto a human cell receptor found in the lung, giving scientists…
HHealth Read More Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical studyFebruary 12, 2026 A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune…
TTechnology Read More Silica nanomatrix enhances immunotherapy for solid tumorsDecember 31, 2025 Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
TTechnology Read More Engineered extracellular vesicles enable antigen-specific regulatory T cell inductionDecember 23, 2025 A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University…
GGenetics Read More Genetic modification enhances “living drugs” for blood cancersSeptember 25, 2025 CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…